To report an adverse event or product quality issue, please email us at reportnow@argenx.com or call us at 1-833-274-9411.
©2026 argenx | Disclaimer | Privacy Policy | Regulations | U.S. Supplemental Privacy Notice
Camilla Sylvest
Executive Director
Camilla Sylvest has served as a member of our Board of Directors since September 2022. Ms. Sylvest most recently served as the Executive Vice President of Commercial Strategy and Corporate Affairs of Novo Nordisk A/S until April 2025.
Ms. Sylvest has more than 28 years of working experience within Novo Nordisk A/S and was based in Switzerland, Denmark, Germany, Malaysia, and Mainland China. Over the years, Ms. Sylvest has headed up Novo Nordisk A/S affiliates of growing size and complexity in Europe. She was also Corporate Vice President of the business area Oceania and Southeast Asia and Senior Vice President and General Manager of the Novo Nordisk A/S region of Mainland China. Ms. Sylvest also served as a member of the board of Danish Crown A/S.
|
Birth Year |
1972 |
|
Nationality |
Danish |
|
Executive / Non-Executive |
Executive |
|
Date of First Pppointment |
08 September 2022 |
|
Current Term |
AGM 2030 |
|
Committee Memberships |
|
Current Board Positions
|
# |
Organization |
|---|---|
|
|
N/A |
Past Board Positions
|
# |
Organization |
|---|---|
|
1 |
World Diabetes Foundation |
|
2 |
Danish Crown A/S |
Explore More
At argenx, every piece of the innovation story connects. See where it leads next.
Grants
Funding research, education, and initiatives that raise the standard of care.
About Us
Discover why we’re more than a unique name.
Newsroom
The latest news and press releases from argenx.
